CRSP is trading 4.3% up at $56.88 today, extending gains as the stock continues to benefit from recent positive sentiment among Wall Street analysts.
- The advance follows a series of price target hikes and reiterated bullish ratings from multiple firms on June 4, 2026, which continue to support the stock's momentum.
- With no fresh company-specific headlines today, the move likely reflects sustained investor confidence in the company's gene-editing pipeline progress.
- CRSP is showing notable relative strength, climbing higher even as the broader market remains modestly weaker.